Eli Lilly Reaches $1 Trillion in Value, Buoyed by Demand for Its Weight Loss Drugs

By Rebecca Robbins from NYT Health https://ift.tt/BcSUjpo
Drugs (Pharmaceuticals), Prices (Fares, Fees and Rates), Diabetes, Stocks and Bonds, GLP-1 RAs (Drug), Insulin, Corporations